Skip to main content

Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter Results on July 20, 2022

Elevance Health (NYSE: ELV) will release second quarter 2022 financial results on July 20, 2022, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

888-947-9963 (Domestic)

866-430-8797 (Domestic Replay)

312-470-0178 (International)

203-369-0943 (International Replay)

The access code for the call is 3972058. There is no access code for the replay. The replay will be available from 11:30 a.m. EDT on July 20, 2022 until the end of the day on August 20, 2022. The call will also be available through a live webcast at www.elevancehealth.com under the “Investors” link. A webcast replay will be available following the call.

About Elevance Health, Inc.

Elevance Health is a lifetime, trusted health partner fueled by its purpose to improve the health of humanity. The company supports consumers, families, and communities across the entire care journey – connecting them to the care, support, and resources they need to lead healthier lives. Elevance Health’s companies serve more than 118 million people through a diverse portfolio of industry-leading medical, digital, pharmacy, behavioral, clinical, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on Twitter and Elevance Health on LinkedIn.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.58
+4.72 (2.30%)
AAPL  261.31
+0.73 (0.28%)
AMD  202.99
-0.38 (-0.19%)
BAC  52.93
+0.16 (0.30%)
GOOG  311.81
+8.25 (2.72%)
META  656.00
+11.22 (1.74%)
MSFT  397.60
-0.86 (-0.22%)
NVDA  188.22
+0.32 (0.17%)
ORCL  153.04
-3.50 (-2.24%)
TSLA  410.87
-0.84 (-0.20%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.